Research Paper Volume 12, Issue 18 pp 18363—18383

A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer

class="figure-viewer-img"

Figure 6. The nomogram to predict risk of cancer recurrence in GSE39582. (A) The nomogram for predicting proportion of patients with disease-free survival. (B) The calibration plots for predicting recurrence at 3 years. Nomogram-predicted probability of recurrence is plotted on the x-axis; actual recurrence is plotted on the y-axis. The solid line represents our nomogram and the vertical bars represent 95 percent confidence intervals. (C) ROC curve based on the nomogram for recurrence probability.